Skip to content

46 Xx Gonadal Dysgenesis C0685837

Published: July 22, 2026Updated: August 26, 2026

A condition affecting ovarian development in individuals with two X chromosomes. May impact puberty and fertility. Treatment typically includes hormone replacement and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 26, 2026Editorial policy

Key facts at a glance

ICD-10
Q55.9
ICD-11
LA00.0
Body system
reproductive
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Gonadoblastoma

Benign or malignant tumor developing in streak gonads, may present as pelvic mass or abdominal pain.

Seek immediate care for sudden abdominal pain, pelvic mass, or unexplained weight loss.

!

Osteopenia

Reduced bone mineral density due to lack of protective estrogen, increasing fracture risk.

Seek evaluation for bone density testing if experiencing bone pain or fractures.

Primary Amenorrhea

(reproductive)

Complete absence of menstrual periods by age 15 or after 3 years of no menstruation following secondary breast development.

Frequency: 95-100% of patients

Lack of Breast Development

(reproductive)

Failure to develop breast tissue (Tanner stage 1) during puberty due to estrogen deficiency.

Frequency: 90-95% of patients

Tall Stature

(constitutional)

Excessive height due to delayed epiphyseal closure from estrogen deficiency, resulting in long limbs.

Frequency: 80-90% of patients

Absent Pubic and Axillary Hair

(reproductive)

Sparse or absent pubic and underarm hair due to lack of ovarian hormone production.

Frequency: 60-70% of patients

Primary Infertility

(reproductive)

Inability to conceive naturally due to absent or non-functional ovarian tissue.

Frequency: 95-100% of patients

Vasomotor Symptoms

(endocrine)

Hot flashes and night sweats similar to menopause due to hypoestrogenism.

Frequency: 40-50% of patients

Vaginal Dryness

(reproductive)

Dryness and thinning of vaginal tissues due to estrogen deficiency, causing discomfort.

Frequency: 40-50% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Hormone replacement therapy

Estrogen and progesterone replacement to induce secondary sexual characteristics and maintain bone health. Typically initiated during expected puberty years and continued long-term.

medication
3

Psychological counseling and support

Mental health support addressing issues of infertility, gender identity concerns, and adjustment to diagnosis. May include individual and family therapy.

psychological

Additional treatment options

Endocrine and gynecologic surveillance

Regular monitoring of hormone levels, bone density, and reproductive organ health through specialized consultations and laboratory testing.

monitoring

Fertility counseling and reproductive options

Discussion of available fertility preservation options including egg donation and assisted reproductive technologies for patients desiring biological children.

complementary

Bone health optimization

Weight-bearing exercise programs and adequate calcium and vitamin D intake to support skeletal health given the hormonal deficiencies.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is 46 Xx Gonadal Dysgenesis C0685837?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Lee PA, Houk CP, Ahmed SF, Hughes IA. Consensus statement on management of intersex disorders. Pediatrics. 2006;118(2):e488-e500.

guideline2006View source →
2

Barros BA, Paula TTSP, Macedo DB, et al. 46,XX Gonadal Dysgenesis: Clinical Presentation, Genetics and Management. Arch Endocrinol Metab. 2021;65(2):167-174.

review2021View source →
3

Hughes IA, Houk C, Ahmed SF, Lee PA. Consensus statement on management of intersex disorders. Arch Dis Child. 2006;91(7):554-563.

review2006View source →
4

American Academy of Pediatrics. Intersex Management: A Position Statement. Pediatrics. 2018;141(3):e20163742.

position_statement2018View source →
5

Eggers S, Sinclair A. Mammalian Gonadal Development and Sex Determination. Curr Top Dev Biol. 2019;134:167-194.

review2019View source →
6

Mendoza-Castrejon J, Avella-Pastorino G, Reyes JM, et al. Meta-analysis of Genetic Factors in 46,XX Disorders of Sex Development. J Clin Endocrinol Metab. 2020;105(9):dgaa412.

meta_analysis2020View source →
7

Melmed S, Auchus RJ, Goldfine AB, Koenig RJ, Rosen CJ. Williams Textbook of Endocrinology. 14th ed. Elsevier; 2019.

textbook2019
8

Wisniewski AB, Batista RL, Costa EMF, et al. Management of 46,XX Disorders of Sex Development: An International Consensus. Endocr Rev. 2019;40(5):1547-1562.

consensus2019View source →
9

Camats N, Liu H, Lafitte A, et al. Clinical and Genetic Characterization of 46,XX Gonadal Dysgenesis: A Prospective Cohort Study. J Med Genet. 2022;59(6):567-575.

clinical_trial2022View source →
10

World Health Organization. Global Disorders of Sex Development Registry: Technical Report. WHO; 2020.

Medication Comparisons

Compare medications used to treat 46 Xx Gonadal Dysgenesis C0685837. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy